Facebook
Linkedin
Twitter
Home
Phil’s Posts
Top Trades
Perspectives
BNN Money Talk
Market Charts
AI
Politics
Biotech/COVID-19
Trading Education Home
Strategy
Contact Us
SIGN IN
SUBSCRIBE
Search
Sign in
Welcome! Log into your account
your username
your password
Log in With Facebook
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
3.7
C
New York
Tuesday, March 19, 2024
Sign In
Home
Phil’s Posts
Top Trades
Perspectives
BNN Money Talk
Market Charts
AI
Politics
Biotech/COVID-19
Trading Education Home
Strategy
Contact Us
SIGN IN
SUBSCRIBE
Home
Tags
GSK
Tag:
GSK
Perspectives
U.K. Medical Journal Questions Avandia License
Ilene
-
September 6, 2010
Perspectives
After Avandia: Does the FDA Have a Drug Problem?
Ilene
-
August 14, 2010
Perspectives
Gilead – Not Your Run of the Mill Mid-Tier Pharma
Ilene
-
July 25, 2010
Hot Items
Something to Love about GSK
Ilene
-
June 23, 2010
Hot Items
Weekly Wrap-Up – Why Does This Rally Give Me the Creeps?
phil
-
April 25, 2010
Hot Items
Prior Weekly Wrap-Up – February Expiration Day Special!
phil
-
February 19, 2010
Hot Items
Wild Weekly Wrap-Up – August in Retrospect
phil
-
August 29, 2009
Hot Items
Pharmboy’s Phavorite Phings
phil
-
August 8, 2009
Hot Items
Monday Market Madness – Pandemic Edition!
phil
-
April 27, 2009
Hot Items
Monday Market Meltdown
phil
-
April 20, 2009
Stay Connected
0
Fans
Like
3,912
Followers
Follow
21,600
Subscribers
Subscribe
- Advertisement -
Latest Articles
Markets
Deposing the King of Israel
Markets
Cheers to health? Uncovering myths around the health benefits of moderate drinking
AI
Something felt ‘off’ – how AI messed with our human research, and what we learned
Markets
Vladimir Putin’s gold strategy explains why sanctions against Russia have failed
Markets
Biden and Trump, though old, are both likely to survive to the end of the next president’s term, demographers explain
Load more